About Alex Brunicki
Form D filings for Cytosolix in 2023 list Alex Brunicki as director.
Alex Brunicki first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Alex Brunicki in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Alex Brunicki works with at each company, as listed on that company's latest Form D.
Cytosolix, Inc. · Form D, Jun 28, 2023
JW
Jason Whitmire
Director
JD
John Deacon
Executive officer and director
CF
Colin Foster
Chief Executive Officer and director